ProNAi Therapeutics Inc (SRRA)

[Value_Investor]

Zero concern for me since I own a Mostly Undervalued Bio-Tech hidden gem which can easily Quadtriple within a very short period based on its Huge Valuation --- both BV and CV plus Huge potential for its Phase3-FDA approval in the coming weeks/months!

Again, SRRA has $0.91 CV and $0.79 CV! One analyst gives $4.00 target --- see the link below!

https://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Wedbush+Assumes%2C+Upgrades+Sierra+Oncology+Inc+%28SRRA%29+at+Outperform/12576449.html

I actually hope the price to drop more so that I could load up my boat!

R/S will be a Positive factor since more institutions will be able to buy SRRA due to their strict policy!